Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kezuo Yindong gel (克痤隐酮凝胶) is a topical traditional Chinese medicine (TCM) combination gel developed and manufactured by companies including Anhui Anke Biotechnology and Hefei Lifang Pharmaceutical. It is approved in China as an over-the-counter (OTC) dermatology product for the treatment of acne, including blackheads, whiteheads (comedones), and pustular acne. The gel is formulated with a combination of active ingredients: danshenone powder (tanshinone, a natural compound extracted from *Salvia miltiorrhiza*), trimethoprim, Vitamin A, and Vitamin E. Kezuo Yindong gel works through a multi-targeted mechanism: danshenone inhibits sebaceous gland secretion and exerts anti-inflammatory and antibacterial effects; trimethoprim acts as a bacterial dihydrofolate reductase (DHFR) inhibitor to suppress the growth of *Cutibacterium acnes*; Vitamin A regulates epithelial cell keratinization to prevent comedone formation; and Vitamin E acts as an antioxidant to protect lipids from peroxidation and synergize with Vitamin A.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kezuo Yindong gel.